검색결과 : 37건
No. | Article |
---|---|
1 |
Construction of a high-yield dengue virus by replacing nonstructural proteins 3-4B without increasing virulence Phanthanawiboon S, Pambudi S, Omokoko MD, Hanabara K, A-Nuegoonpipat A, Kamitani W, Ikuta K, Kurosu T Biochemical and Biophysical Research Communications, 495(1), 1221, 2018 |
2 |
A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines Toki Y, Sasaki K, Tanaka H, Yamamoto M, Hatayama M, Ito S, Ikuta K, Shindo M, Hasebe T, Nakajima S, Sawada K, Fujiya M, Torimoto Y, Ohtake T, Kohgo Y Biochemical and Biophysical Research Communications, 476(4), 501, 2016 |
3 |
Probiotic-derived polyphosphate improves the intestinal barrier function through the caveolin-dependent endocytic pathway Tanaka K, Fujiya M, Konishi H, Ueno N, Kashima S, Sasajima J, Moriichi K, Ikuta K, Tanabe H, Kohgo Y Biochemical and Biophysical Research Communications, 467(3), 541, 2015 |
4 |
microRNA-26a and-584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA Konishi H, Fujiya M, Ueno N, Moriichi K, Sasajima J, Ikuta K, Tanabe H, Tanaka H, Kohgo Y Biochemical and Biophysical Research Communications, 467(4), 847, 2015 |
5 |
Proteolysis of abnormal prion protein with a thermostable protease from Thermococcus kodakarensis KOD1 Koga Y, Tanaka S, Sakudo A, Tobiume M, Aranishi M, Hirata A, Takano K, Ikuta K, Kanaya S Applied Microbiology and Biotechnology, 98(5), 2113, 2014 |
6 |
Human monoclonal antibodies derived from a patient infected with 2009 pandemic influenza A virus broadly cross-neutralize group 1 influenza viruses Pan Y, Sasaki T, Kubota-Koketsu R, Inoue Y, Yasugi M, Yamashita A, Ramadhany R, Arai Y, Du A, Boonsathorn N, Ibrahim MS, Daidoji T, Nakaya T, Ono K, Okuno Y, Ikuta K, Watanabe Y Biochemical and Biophysical Research Communications, 450(1), 42, 2014 |
7 |
A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses Boonsathorn N, Panthong S, Koksunan S, Chittaganpitch M, Phuygun S, Waicharoen S, Prachasupap A, Sasaki T, Kubota-Koketsu R, Yasugi M, Ono K, Arai Y, Kurosu T, Sawanpanyalert P, Ikuta K, Watanabe Y Biochemical and Biophysical Research Communications, 452(3), 865, 2014 |
8 |
Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection (vol 423, pg 867, 2012) Setthapramote C, Sasaki T, Puiprom O, Limkittikul K, Pitaksajjakul P, Pipattanaboon C, Sasayama M, Leuangwutiwong P, Phumratanaprapin W, Chamnachanan S, Kusolsuk T, Jittmittraphap A, Asai A, Arias JF, Hirai I, Kuhara M, Okuno Y, Kurosu T, Ramasoota P, Ikuta K Biochemical and Biophysical Research Communications, 432(1), 200, 2013 |
9 |
A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication Pambudi S, Kawashita N, Phanthanawiboon S, Omokoko MD, Masrinoul P, Yamashita A, Limkittikul K, Yasunaga T, Takagi T, Ikuta K, Kurosu T Biochemical and Biophysical Research Communications, 440(3), 393, 2013 |
10 |
Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection Setthapramote C, Sasaki T, Puiprom O, Limkittikul K, Pitaksajjakul P, Pipattanaboon C, Sasayama M, Leuangwutiwong P, Phumratanaprapin W, Chamnachanan S, Kusolsuk T, Jittmittraphap A, Asai A, Arias JF, Hirai I, Kuhara M, Okuno Y, Kurosu T, Ramasoota P, Ikuta K Biochemical and Biophysical Research Communications, 423(4), 867, 2012 |